Literature DB >> 10578237

Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism.

S Ueno1, M Nakamura, M Mikami, K Kondoh, H Ishiguro, T Arinami, T Komiyama, H Mitsushio, A Sano, H Tanabe.   

Abstract

Human dopamine transporter gene (DAT1) has a variable number of tandem repeats (VNTR) in its 3'-untranslated region (UTR). The association between the VNTR polymorphism and neuropsychiatric disorders has been studied, but their relationship is still unclear. Here we identified a novel polymorphism in the 3'-UTR of the DAT1 gene, G2319A, and a significant association between the polymorphism and alcoholism was observed in both genotypic and allelic frequencies (P = 0.040 and 0.019, extended Fisher's exact test, respectively). There was a significant gene dose effect on the risk for alcoholism associated with the 2319-A allele (chi2 = 6.16, df = 2, P = 0.046, linearity tendency test: Cochranq-Armitage analysis). Moreover, in the haplotype analysis with G2319A- and VNTR-polymorphisms, a positive gene dose efffect on the risk with the A10 allele (P = 0.044, linearity tendency test) and a negative gene dose effect with the G10 allele (P = 0.010, linearity tendency test) for alcoholism were significantly detected. Odds ratio for alcoholism with the A10 and G10 alleles were 1.76 (1.12-2.76) and 0.53 (0.32-0.79), respectively. These results indicate that the DAT1 gene may confer vulnerability to alcoholism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10578237     DOI: 10.1038/sj.mp.4000562

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  26 in total

Review 1.  The genetics of alcoholism and alcohol abuse.

Authors:  M A Enoch; D Goldman
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

2.  Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls.

Authors:  Mingqing Xu; Zhicheng Lin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-13       Impact factor: 5.067

3.  Dopaminergic control of anxiety in young and aged zebrafish.

Authors:  Victoria Kacprzak; Neil A Patel; Elizabeth Riley; Lili Yu; Jing-Ruey J Yeh; Irina V Zhdanova
Journal:  Pharmacol Biochem Behav       Date:  2017-04-10       Impact factor: 3.533

4.  Dopamine dynamics associated with, and resulting from, schedule-induced alcohol self-administration: analyses in dopamine transporter knockout mice.

Authors:  Guy Mittleman; Stanford B Call; Jody L Cockroft; Dan Goldowitz; Douglas B Matthews; Charles D Blaha
Journal:  Alcohol       Date:  2011-02-26       Impact factor: 2.405

Review 5.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

6.  DAT1 and Alcohol Use: Differential Responses to Life Stress during Adolescence.

Authors:  John M Stogner
Journal:  Crim Justice Stud (Abingdon)       Date:  2015-01-28

7.  Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence.

Authors:  Daijun Ling; Tianhua Niu; Yan Feng; Houxun Xing; Xiping Xu
Journal:  J Hum Genet       Date:  2003-12-18       Impact factor: 3.172

8.  Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations.

Authors:  L V K S Bhaskar; Kumarasamy Thangaraj; Connie J Mulligan; Samiksha Wasnik; Amrita Nandan; Varun Kumar Sharma; Vishwas Sharma; Alla Govardhana Reddy; Lalji Singh; Vadlamudi Raghavendra Rao
Journal:  Neurol Sci       Date:  2009-09-25       Impact factor: 3.307

Review 9.  Genes associated with addiction: alcoholism, opiate, and cocaine addiction.

Authors:  Mary Jeanne Kreek; David A Nielsen; K Steven LaForge
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 10.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.